Kathrin Dvir, MD, MSc, discusses how biomarker-driven care, targeted therapies, and evolving sequencing are shaping modern breast cancer treatment.

India's disease burden is undergoing a structural shift. According to the recent data, non-communicable diseases account for ...

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

Cells from cancerous tumors can spread, or metastasize, throughout the body. Researchers have long sought to understand what determines where those cells will go and thrive in order to more ...

The survey of 152 clinicians also found that turnaround time and payor coverage are among the most important considerations for doctors when ordering cancer testing.

Colorectal cancer is now the leading cause of cancer deaths among people younger than 50 in the United States, according to a study published Thursday in the Journal of the American Medical ...

Division of Gastroenterology & Hepatology, Department of Medicine (N.J.S.), Mayo Clinic, Phoenix, AZ. Genetic Counseling program, Arizona State University, Tucson ...

NEW YORK – Backed by promising results from a recent small study, Arima Genomics believes that its Hi-C lymphoma assay can eventually replace fluorescence in situ hybridization (FISH)-based tests to ...

Overall, treatment of metastatic triple-positive breast cancer is shifting toward precision-driven regimens that combine HER2 blockade with endocrine and targeted agents tailored to disease burden, ...

Background: Colorectal cancer (CRC) shows significant inter-population heterogeneity in its genomic landscape, yet Middle Eastern populations are underrepresented in large-scale sequencing studies.

Researchers have refined a powerful DNA sequencing tool that can uncover hidden mutations that occur naturally in our bodies as we age. In the largest study to date, they have used the tool to provide ...